σ1R Ligands |
1 |
N,N-dialkyl and N-alkyl-N-aralkyl
fenpropimorph-derivatives |
NCI-H460, DU145, MCF7, SKOV-3,
MB-MDA231 |
multiplex cytotoxicity
assays |
(101) |
2 |
SKOV-3 |
5 |
MCF-7 |
13, 14
|
spipethiane derivatives |
MCF-7/ADR |
annexin V-FITC assay, tail-flick assay |
|
20, 21
|
spirocyclic thienopyran and thienofuran derivatives |
A427 |
retinal ganglion assay, capsaicin assay,
crystal violet assay,
LDH assay |
(83, 111, 113, 178) |
36 |
7,9-diazabicyclo[4.2.2]decane
derivative |
A427 |
crystal violet assay |
(131) |
ent-38, 40, ent-40, ent-41, 42, ent-42
|
2,5-diazabicyclo[2.2.2]octane
derivatives |
A427 |
crystal violet assay, annexin
V-FITC assay |
(132) |
ent-38, 39, ent-41, 42
|
5637 |
σ2R Ligands |
SWIII-123 |
granatane derivative |
SKOV-3, CaOV-3, BG-1 |
MTS assay |
(146) |
49 |
indole derivatives |
MCF-7, MCF-7/dox,
DU145, C6, A549/DX |
MTT
assay, cell cycle analysis |
(158, 159, 162) |
51 |
DU145, MCF-7, C6 |
(159) |
F281 |
carbazole derivative |
Panc02 |
MTT assay |
(36) |
PB221 |
tetralin
derivative |
Panc02, ALTS1C1, UN-KC6141 |
MTT assay, caspase-Glo assay |
(36, 79) |
CM572, CM764
|
1,3-benzoxazol-2(3H)-one derivatives |
SK-N-SH |
MTT
assay |
(112, 166) |
66 |
6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivative |
Huh-7, KYSE-140 |
CCK8 assay |
(170) |
86 |
3-alkoxyisoxazole
derivative |
143B, MOS-J |
crystal violet
assay, annexin V assay |
(176) |